Physician

Adam Howard Wiener, D.O.

According to 2025 Medicare claims, Adam Wiener, D.O. (NPI: 1215102041) practices dermatology in the Palm Bay-Melbourne-Titusville, FL market, with the plurality of this provider's patient population coming from Brevard, FL. This provider's primary affiliated billing organization is STEPHEN HORNELL, MD, PA (NPI: 1720157696; TIN: 591761147) and primary practice location at 32901-3152.

Wiener's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,106 traditional Medicare patients, billed 9,115 HCPCS/CPT codes, and received $755,481 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 829 prescription claims across 339 beneficiaries totaling $470,441 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 108 records totaling $6,310. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $133,083 to $470,441. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$415K$831K2015 Medicare payment: $620,338 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $606,977 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $614,671 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $556,284 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $646,897 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $698,971 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $597,024 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $636,505 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $830,611 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $755,481 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201598310,143$620,338
20161,0199,781$606,977
201799410,047$614,671
20181,0219,994$556,284
20191,08811,844$646,897
20201,00316,732$698,971
20219348,226$597,024
20228607,121$636,505
20239669,668$830,611
20241,1069,115$755,481

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$235K$470K2015 Drug cost: $133,083 (USD; Tot_Drug_Cst)2016 Drug cost: $116,437 (USD; Tot_Drug_Cst)2017 Drug cost: $191,725 (USD; Tot_Drug_Cst)2018 Drug cost: $157,119 (USD; Tot_Drug_Cst)2019 Drug cost: $173,186 (USD; Tot_Drug_Cst)2020 Drug cost: $245,060 (USD; Tot_Drug_Cst)2021 Drug cost: $174,763 (USD; Tot_Drug_Cst)2022 Drug cost: $225,286 (USD; Tot_Drug_Cst)2023 Drug cost: $332,365 (USD; Tot_Drug_Cst)2024 Drug cost: $470,441 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154091,040$133,083
2016398951$116,437
2017403973$191,725
2018402985$157,119
20194451,130$173,186
20204551,185$245,060
2021396876$174,763
2022370883$225,286
2023349769$332,365
2024339829$470,441

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths302397$74
11102Biopsy of related skin growth, first growth383495$60
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more7431,326$59
17000Destruction of precancer skin growth, 1 growth510755$34
17003Destruction of precancer skin growth, 2-14 growths4043,024$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab22648$121,256
Betamethasone DipropionateBetamethasone Dipropionate461,268$2,639
Clobetasol PropionateClobetasol Propionate23676$2,308
KetoconazoleKetoconazole972,864$1,776
FluocinonideFluocinonide391,134$1,745

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.108$6,310PFIZER INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adam Howard Wiener, D.O.?

Tedicare shows public-source Medicare data for Adam Howard Wiener, D.O. (NPI 1215102041), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Howard Wiener, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam Howard Wiener, D.O.?

Adam Howard Wiener, D.O. is linked to STEPHEN HORNELL, MD, PA (billing NPI 1720157696) in the available physician profile data.

Does Adam Howard Wiener, D.O. have Open Payments data?

Adam Howard Wiener, D.O. has 108 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.